Further preclinical and translational studies will have to be carried out in order to gain a deeper understanding of physiological prestin circulation within the cochlear fluids and systemic blood system, and its potential suitability as a clinical biomarker for HL. The gene discussed is SLC26A5; the disease is Hodgkins lymphoma.